Evotec Investor Presentation Deck slide image

Evotec Investor Presentation Deck

evotec PAGE 17 Deal value in $bn 5.0 2.5 2.0 1.5 1.0 0.5 BMS & Evotec create the globally leading TPD¹) alliance Analysis of selected licensing deals – strong momentum in the last 2 years - 0 Size of bubble denotes breadth of pipeline Amphista/ BMS Nurix/ Sanofi Lycia/ Lilly Amphista/ Merck Discovery 1) Targeted Protein Degradation Source: Company webpages, Evotec analysis evotec Bristol Myers Squibb Seed/ Lilly Plexium/ Amgen Vividion/ Bayer Pre-Clinical Arvinas/ Pfizer Kymera/ Sanofi Clinical Foghorn/ Lilly
View entire presentation